A pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancer
Takashi Yokoi, Takeshi Tamaki, Toshiki Shimizu, Shosaku NomuraFirst Department of Internal Medicine, Kansai Medical University, Moriguchi City, Osaka, JapanBackground: Low-dose metronomic (LDM) chemotherapy is a novel approach that involves frequent administration of a low dose of chemotherapeutic a...
Saved in:
Main Authors: | Yokoi T, Tamaki T, Shimizu T, Nomura S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/66978b224fa6412a821f19f149590fb4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improvement of intratumor microdistribution of PEGylated liposome via tumor priming by metronomic S-1 dosing
by: Doi Y, et al.
Published: (2016) -
Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy
by: Sugiura Y, et al.
Published: (2013) -
Salvage Chemotherapy in Patients with Previously Treated Thymic Carcinoma
by: Kyoichi Kaira, et al.
Published: (2021) -
Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy
by: Hua H, et al.
Published: (2017) -
Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment
by: Richard Derman, et al.
Published: (2009)